BioMap Unveils Ambitious Collaborations with 11 Industry Partners at the 2026 Summit

BioMap Strengthens its Position in AI Bio-Computing



The International Bio-Computing Innovation Summit 2026 took place on November 6 at the Hong Kong Convention and Exhibition Centre, where BioMap, a leading developer in AI foundation models for life sciences, revealed an exciting array of strategic collaborations with 11 key partners. This initiative, supported by the Hong Kong Investment Corporation Limited (HKIC), seeks to accelerate advancements in drug research and agricultural techniques through artificial intelligence.

During the summit, which attracted significant attention from local and international stakeholders, renowned guests including Mr. Paul Chan, Financial Secretary of the HKSAR Government; Ms. Clara Chan, Chief Executive Officer of HKIC; and Mr. Wei Liu, Co-Founder and CEO of BioMap, graced the event, underscoring its importance and potential impact. The collaborations announced cover various domains including innovative drug research and development, Traditional Chinese Medicine studies, and agricultural breeding, aiming to propel AI applications in life sciences and facilitate the commercialization of research outcomes from Hong Kong.

Key Collaborative Projects



Among the standout projects unveiled, BioMap has partnered with the University of Hong Kong (HKU) to enhance the Breast Cancer Virtual Cell Large Model project. This initiative leverages AI technologies to simulate the behaviors of breast cancer cells, offering researchers a deeper understanding of this critical disease and potentially uncovering new treatment pathways.

In another significant partnership with Hong Kong Baptist University (HKBU), BioMap is set to establish an AI Traditional Chinese Medicine Joint Laboratory. This innovative lab will blend AI data analysis with hands-on experimental validation, aimed at elucidating the mechanisms behind various TCM ingredients.

Furthermore, BioMap's collaboration with PepLib revolves around the Novel Peptide Drug Incubation initiative. This project will utilize AI to expedite the research and development of pioneering peptide and cyclic peptide therapeutics, promising a new frontier in drug innovation.

Advancements in Agricultural Technology



In the realm of agricultural technology, BioMap's partnership with Soy-Sky FarmTech is particularly intriguing. Together, they are advancing an AI Breeding Platform that integrates biological foundation models with crop data on genetics and traits. This collaborative effort aims to enhance breeding decisions and establish a robust ecosystem for AI-driven agricultural innovations, especially under the Belt and Road Initiative framework.

Moreover, in the pursuit of expanding into international markets, BioMap will collaborate with DEFTA Partners to explore opportunities within Japan and other overseas markets through their DEFTA Overseas Market Expansion Program.

As part of their efforts to innovate in research infrastructure and technology, BioMap is teaming up with Coyote Bioscience for an

Topics Other)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.